HBI up +1.31% percent right now. $HBI High is at 110.85 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
HBI up +1.31% percent right now. $HBI High is at 110.85 and the Low 109.64 with current volume of 370,039.

Recent News posted below.

HBI Hanesbrands Inc Recent Headline News

Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Hanesbrands Is Down 0.6% (HBI)
Comtex SmarTrend(R) - Mon Nov 10, 8:52AM CST
When Hanesbrands (NYSE:HBI) reported earnings 12 days ago on October 29th, 2014, analysts, on average, expected the company to report earnings of $1.68 on sales of $1.4 billion. Hanesbrands actually reported earnings of $1.73 per share on sales of $1.4 billion, beating EPS estimates by $0.05 and missing revenue estimates by $13.4 million. Since the company's report, shares of Hanesbrands have fallen from $110.01 to $109.33, representing a loss of 0.6% in the past 12 days.
HBI: 110.45 (+1.12)

Real Money's Brian Sozzi: A Primer on Investing in Retail Stocks
at The Street - Wed Nov 05, 11:38AM CST
Some thoughts on the outlook of the retail sector and what to look for before you invest.
COH: 33.92 (+0.26), TJX: 63.76 (-0.24), NKE: 94.88 (+1.10), TGT: 65.30 (+1.13), WMT: 80.06 (+1.29), HBI: 110.45 (+1.12), THRX: 13.55 (-0.72), KORS: 69.69 (-0.26), GPS: 38.49 (-0.34), RL: 173.48 (-0.52), LULU: 43.01 (-0.75)

Columbia Sports Gains on Strong Q3 Earnings; Ups FY View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 9:20AM CST
Shares of Columbia Sportswear Company (COLM) grew 5.0% since it reported strong third-quarter 2014 results on Oct 30 wherein both earnings and sales beat expectations.
OXM: 65.52 (+0.67), COLM: 40.30 (-0.11), GII: 49.62 (+0.26), HBI: 110.45 (+1.12)

L Brands Looks Promising, Increases Q3 Earnings Projection - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 4:51PM CST
Shares of L Brands (LB) rose 3.2% during after-market trading hours, after this specialty retailer of women's intimate and other apparel, beauty and personal care products, raised its third-quarter fiscal 2014 earnings guidance.
LB: 76.04 (+0.43), GIL: 58.39 (-0.43), COLM: 40.30 (-0.11), HBI: 110.45 (+1.12)

Michael Kors Q2 Earnings Top Estimates on Sustained Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 9:28AM CST
Michael Kors Holdings Ltd. (KORS) posted second-quarter fiscal 2015 earnings per share of $1.00 came miles ahead of the Zacks Consensus Estimate of 88 cents per share while rising 40.8% year over year.
COH: 33.92 (+0.26), HBI: 110.45 (+1.12), KORS: 69.69 (-0.26), RL: 173.48 (-0.52)

Companies Release Third Quarterly Results - Research Reports on Avon, BorgWarner, Kellogg, Hanes and Bunge
PR Newswire - Tue Nov 04, 8:15AM CST
Today, Analysts Review released its research reports regarding Avon Products, Inc. (NYSE: AVP), BorgWarner Inc. (NYSE: BWA), Kellogg Company (NYSE: K), HanesBrands Inc. (NYSE: HBI) and Bunge Ltd. (NYSE: BG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7685-100free.
BWA: 56.79 (-0.89), BG: 88.87 (+0.11), AVP: 10.38 (-0.20), HBI: 110.45 (+1.12), K: 63.83 (+0.17)

Clorox Beats Q1 Earnings Estimates, Retains FY15 Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 9:27AM CDT
The Clorox Company (CLX) started fiscal 2015 on a strong note wherein both top and bottom lines marked a year-over-year improvement and also came ahead of the Zacks Consensus Estimate.
CLX: 101.11 (+0.32), CBK: 6.72 (+0.02), HBI: 110.45 (+1.12), ARO: 2.92 (-0.23)

Hanesbrands Set to Possibly Rebound After Yesterday's Selloff of 3.05%
Comtex SmarTrend(R) - Thu Oct 30, 4:04PM CDT
Hanesbrands (NYSE:HBI) traded in a range yesterday that spanned from a low of $105.05 to a high of $110.58. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $108.77 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
HBI: 110.45 (+1.12)

Hanesbrands Tops Earnings, Lags Revenues; Ups FY View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:39PM CDT
Hanesbrands Inc.'s (HBI) third-quarter fiscal 2014 earnings per share of $1.73 beat the Zacks Consensus Estimate by a penny and also increased 41% from the prior-year quarter.
GIL: 58.39 (-0.43), GIII: 81.40 (+1.19), VNCE: 35.60 (+0.85), HBI: 110.45 (+1.12)

HANESBRANDS
at Investor's Business Daily - Wed Oct 29, 5:32PM CDT
HANESBRANDS (HBI), an underwear and casualwear maker, said Q3 EPS rose 41% to $1.73, beating by 5 cents. Sales grew 17% to $1.4 bil vs. views of $1.42 bil. Shares fell 1.3% to 108.63.
HBI: 110.45 (+1.12)

HanesBrands Reports Third-Quarter 2014 Financial Results
Business Wire - Wed Oct 29, 3:02PM CDT
--- Excluding Actions, Net Sales up 17%, Operating Profit up 23% and EPS up 41%
HBI: 110.45 (+1.12)

Ralph Lauren Q2 Earnings Beat, Trims View on Currency Impact - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 10:17AM CDT
Ralph Lauren Corporation's (RL) earnings of $2.25 per share in the quarter surpassed the Zacks Consensus Estimate of $2.05 and rose nearly 1% from the year-ago quarter figure of $2.23 per share.
CHKE: 17.75 (+0.24), HBI: 110.45 (+1.12), RL: 173.48 (-0.52), LULU: 43.01 (-0.75)

HanesBrands announces quarterly dividend of USD0.30 per share
M2 - Wed Oct 29, 4:16AM CDT
HanesBrands (NYSE:HBI), a marketer of branded everyday basic apparel, reported on Wednesday that its board of directors authorised a regular quarterly cash dividend of USD0.30 per share.
HBI: 110.45 (+1.12)

HanesBrands Declares Regular Quarterly Cash Dividend
Business Wire - Tue Oct 28, 3:39PM CDT
HanesBrands (NYSE: HBI), a leading global marketer of everyday basic apparel under world-class brands, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.30 per share to be paid Dec. 9, 2014, for stockholders of record at the close of business Nov. 18, 2014.
HBI: 110.45 (+1.12)

Coach Q1 Earnings Beat Estimates as International Sales Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 2:50PM CDT
Coach (COH) posted first-quarter fiscal 2015 earnings of 53 cents a share that came ahead of the Zacks Consensus Estimate of 45 cents on higher international sales.
COH: 33.92 (+0.26), GIL: 58.39 (-0.43), HBI: 110.45 (+1.12), LULU: 43.01 (-0.75)

Callaway Golf (ELY) Incurs Narrower Q3 Loss; Ups FY View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:00PM CDT
Callaway Golf Company (ELY) reported better than expected sales during the third quarterof fiscal 2014 backed by higher market share.
ELY: 7.92 (+0.06), HBI: 110.45 (+1.12), MBUU: 18.30 (-0.15), PII: 157.21 (+0.71)

Maidenform® Announces Celebrity Stylist Micaela Erlanger As Brand Ambassador And Spokesperson
PR Newswire - Tue Oct 28, 7:13AM CDT
Maidenform, a leading intimate apparel brand, announces that celebrity stylist Micaela Erlanger has joined the brand as an ambassador and spokesperson through March 2015. Erlanger will act as a guide to the Maidenform customer, offering expert tips, product picks and styling insight via the brand's website and social media platforms.
HBI: 110.45 (+1.12)

Hanes Supports Breast Cancer Awareness Month With Relaunch Of "Mammogram Monologues" Campaign
PR Newswire - Thu Oct 23, 10:17AM CDT
October is National Breast Cancer Awareness Month, and Hanes is again partnering with the National Breast Cancer Foundation to raise awareness for early detection and testing for breast cancer. Additionally, Hanes has joined forces with influential bloggers to reignite their successful "Mammogram Monologues" social campaign, an initiative designed to make women more comfortable with the mammogram exam process. As part of the campaign, influencers will share personal mammogram experiences, stories related to breast cancer, and anecdotes about how breast cancer has touched their lives throughout the month of October.
HBI: 110.45 (+1.12)

Under Armour Beats on Q3 Earnings & Revenues, Guides Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 8:37AM CDT
Under Armour (UA) posted impressive third-quarter results and provided an upbeat outlook for 2014.
UA: 68.68 (+1.70), GIL: 58.39 (-0.43), HBI: 110.45 (+1.12), LULU: 43.01 (-0.75)

Video: Top 4 Earnings Reports To Watch Thursday
at Investor's Business Daily - Wed Oct 22, 2:25PM CDT
The top four companies reporting earnings on Thursday all have a high IBD Composite Rating, which grades stocks based on fundamental and technical factors. These stocks are also among the steadiest earnings growers out of all the stocks in the...
UA: 68.68 (+1.70), ALXN: 194.21 (+0.40), HBI: 110.45 (+1.12), UNP: 121.04 (+2.29), CELG: 107.68 (+1.23)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 69

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 80

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 18

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 118

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 287

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 277

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 153

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 208

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading

Top 5 Most Recently Viewed Articles

ArisGlobal's Commitment to Ethical AI Enhances Patient Safety

Updated Category News Views 108

ArisGlobal's Commitment to Ethical AI and Patient Safety The EU AI Pact is a significant step for organizations preparing for the EU AI Act, the groundbreaking legislation that regulates artificial intelligence globally. ArisGlobal, a pioneering technology firm in life sciences, recently signed the EU AI Pact, emphasizing its dedication to responsible AI practices and its...

Continue Reading
Important Update for PubMatic, Inc. Investors on Class Action

Updated Category News Views 110

Important Update for PubMatic, Inc. Investors The Gross Law Firm has issued an important notification to shareholders of PubMatic, Inc. (NASDAQ: PUBM) regarding a significant class action lawsuit. This might be crucial for investors who acquired shares during the specified class period. Encouragement to Shareholders Investors who purchased PUBM shares during the specified...

Continue Reading
Key Insights on De La Rue plc's Recent Trading Activities

Updated Category News Views 127

Overview of Trading Disclosures for De La Rue plc The latest report highlights important trading actions relating to De La Rue plc, showcasing the dealings by the exempt principal trader, Investec Bank plc, within a client-serving capacity. Under the Takeover Code, it's vital to transparently share relevant trading information that affects the stakeholders involved. Key...

Continue Reading
Investors Encouraged to Join Indivior PLC Class Action Lawsuit

Updated Category News Views 39

Investors Invited to Participate in Indivior PLC Class Action Lawsuit The Law Offices of Frank R. Cruz are actively seeking investors who have experienced substantial losses due to alleged securities fraud related to Indivior PLC (INDV). This presents a vital opportunity for shareholders to come forward as potential lead plaintiffs in this class action lawsuit. The case...

Continue Reading
ProCap Financial Emerges Following Strategic Business Combination

Updated Category News Views 242

ProCap Financial Commences Trading on Nasdaq In an exciting development within the financial sector, ProCap Financial is poised to start trading on the Nasdaq Global Market on a forthcoming date under the ticker symbol "BRR." This marks a significant milestone not only for ProCap BTC, LLC but also for the entire financial community that seeks innovative solutions in...

Continue Reading